Abionyx Pharma (France) Buy Hold or Sell Recommendation

ABNX Stock  EUR 1.24  0.02  1.64%   
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Abionyx Pharma SA is 'Cautious Hold'. Macroaxis provides Abionyx Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABNX positions.
  
Check out Abionyx Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Abionyx and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Abionyx Pharma SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Abionyx Pharma Buy or Sell Advice

The Abionyx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Abionyx Pharma SA. Macroaxis does not own or have any residual interests in Abionyx Pharma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Abionyx Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Abionyx PharmaBuy Abionyx Pharma
Cautious Hold

Market Performance

Very WeakDetails

Volatility

DangerousDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves slightly opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Abionyx Pharma SA has a Mean Deviation of 1.81, Standard Deviation of 2.58 and Variance of 6.63
We provide trade advice to complement the prevailing expert consensus on Abionyx Pharma SA. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Abionyx Pharma is not overpriced, please confirm all Abionyx Pharma SA fundamentals, including its shares owned by insiders, price to earning, and the relationship between the shares outstanding and shares owned by institutions .

Abionyx Pharma Trading Alerts and Improvement Suggestions

Abionyx Pharma SA generated a negative expected return over the last 90 days
Abionyx Pharma SA may become a speculative penny stock
The company reported the revenue of 675 K. Net Loss for the year was (5.82 M) with profit before overhead, payroll, taxes, and interest of 259 K.
Abionyx Pharma SA has accumulated about 8.33 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Roughly 32.0% of the company shares are held by company insiders

Abionyx Pharma Returns Distribution Density

The distribution of Abionyx Pharma's historical returns is an attempt to chart the uncertainty of Abionyx Pharma's future price movements. The chart of the probability distribution of Abionyx Pharma daily returns describes the distribution of returns around its average expected value. We use Abionyx Pharma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Abionyx Pharma returns is essential to provide solid investment advice for Abionyx Pharma.
Mean Return
-0.09
Value At Risk
-3.1
Potential Upside
5.56
Standard Deviation
2.58
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Abionyx Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Abionyx Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Abionyx Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Abionyx Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Abionyx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.08
β
Beta against Dow Jones-0.58
σ
Overall volatility
2.58
Ir
Information ratio -0.05

Abionyx Pharma Volatility Alert

Abionyx Pharma SA exhibits very low volatility with skewness of 1.39 and kurtosis of 3.03. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Abionyx Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Abionyx Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Abionyx Pharma Fundamentals Vs Peers

Comparing Abionyx Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Abionyx Pharma's direct or indirect competition across all of the common fundamentals between Abionyx Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Abionyx Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Abionyx Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Abionyx Pharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Abionyx Pharma to competition
FundamentalsAbionyx PharmaPeer Average
Return On Equity-0.92-0.31
Return On Asset-0.29-0.14
Profit Margin(1.78) %(1.27) %
Operating Margin(1.78) %(5.51) %
Current Valuation51.58 M16.62 B
Shares Outstanding28.09 M571.82 M
Shares Owned By Insiders32.46 %10.09 %
Shares Owned By Institutions11.99 %39.21 %
Price To Earning17.78 X28.72 X
Price To Book5.91 X9.51 X
Price To Sales15.30 X11.42 X
Revenue675 K9.43 B
Gross Profit259 K27.38 B
EBITDA(5.7 M)3.9 B
Net Income(5.82 M)570.98 M
Cash And Equivalents8.33 M2.7 B
Cash Per Share0.38 X5.01 X
Total Debt3.9 M5.32 B
Debt To Equity0.18 %48.70 %
Current Ratio2.92 X2.16 X
Book Value Per Share0.31 X1.93 K
Cash Flow From Operations(6.69 M)971.22 M
Earnings Per Share(0.21) X3.12 X
Target Price5.5
Number Of Employees6218.84 K
Beta0.33-0.15
Market Capitalization52.53 M19.03 B
Total Asset21.83 M29.47 B
Z Score7.88.72
Net Asset21.83 M

Abionyx Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Abionyx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Abionyx Pharma Buy or Sell Advice

When is the right time to buy or sell Abionyx Pharma SA? Buying financial instruments such as Abionyx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Abionyx Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Money Funds Thematic Idea Now

Money Funds
Money Funds Theme
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Abionyx Stock

Abionyx Pharma financial ratios help investors to determine whether Abionyx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abionyx with respect to the benefits of owning Abionyx Pharma security.